.

Thursday, April 25, 2019

Intravenous Paracetamol to manage pain Research Proposal

Intravenous Paracetamol to manage trouble oneself - Research Proposal ExamplePatients atomic number 18 bound to come across pain later the effect of anaesthesia given before surgery is finally gone. White et al (2010) had reported a result of surveys in Europe and the USA, stating the need to improve the quality of managing pain after surgeries. The practice then was to use opioids which have multiple adverse effects (AEs) constipation, urinary retention, vomiting/nausea, hypersensitive reactions, confusion, sedation, respiratory depression, and hypotension. These AEs increased the cost of hospitalization and delayed the recovery of patients. A better way of managing pain was then under clinical trials for 15 years. It involved the use of analgesics that require less opioids. There was no FDA approved Intravenous acetaminophen at that time. Cadence Pharmaceuticals Inc. patented the first I.V. Paracetamol in July 8, 2011 (US SEC 2011) and produced Ofirmev which, until the present, does non have a competitor worldwide due to the recognized protection for intellectual property. This gathered bear witness about the efficacy and safety of apply Ofirmev (the only available US FDA approved Intravenous Acetaminophen in the market), how it benefits patients, and actually improved the quality of pain counseling. There were evidences based on actual clinical trials with patients that proved the efficacy and safety of Intravenous Paracetamol to neonates, infants, children, adolescents, adults, and even the elderly with age 65 years ageing and above, for mild, moderate, and unrelenting cases of pain, especially postoperative pain. Introduction Focus is given to the extent of actual benefits observed in many clinical trials, limitations, and clarifications pertaining to the use of I.V. Paracetamol use for postoperative pain management. As a background, over a year after the introduction of the US FDA approved injectable pain reliever under the tarnish name Ofirmev , doctors have pursued further clinical trials in Europe and the USA covering thousands of patients. wiz of the references of this paper took the effort to search for registered clinical trials in order to learn more about efficacy, safety, equaliser of patients who responded favourably or not, to mostly postoperative cases. It would be interesting to know under what conditions I.V. Acetaminophen should be administered to patients. What procedures were followed? Why? There atomic number 18 very young to very old patients who encounter the need for surgery. How should it be given? In actual experiences, was it safe to administer the use of this analgesic to any of such patients? What are the chances of having a satisfied postoperative patient after using Ofirmev? For one thing, doctors excluded patients with symptoms pointing to contraindications against the use of Intravenous Acetaminophen. These are situations wherein patients have severe liver disease, hepatic impairment and ac tive hepatic disease, allergic to acetaminophen, chronic malnutrition, severe renal impairment, and to patients with history of being alcoholic. The US FDA (2012a) announced that the limitation per dosage of acetaminophen should be 325 mg. duration the total maximum dosage per day must not exceed 4 grams. For infants, the recommended dose of the US FDA for acetaminophen in vial is only 50 mL per child weighing less than 33 kg. (US FDA 2012b, p.12) There were cases of acetaminophen over dosages in infants and adults in the past. For adults, from 1998 to 2003, a total of 131 people experienced acute accent liver failure in the United States due to acetaminophen overdose (US FDA 2012a). Nonetheless, the medical practice has changed from using mostly opioids like morphine and non-steroidal anti-inflammatory drugs (NSAIDs) to the preferred use of Intravenous Acetaminophen in faction with less opioids only when needed, for reasons that will be disclosed in this paper. Problem and Purpo se Quality management of postoperative pain requires provisions for the comfortable recovery of patients right after surgery. Unfortunately, the use of opioids to

No comments:

Post a Comment